*Eiji Shigetomi^1,2, Hideaki Suzuki^1,2, Yuki Nagai^1,2, Yukiho J Hirayama², Sano Fumikazu^3,2,1, Kohei Yoshihara⁴, Keisuke Koga⁵, Toru Tateoka^6,1, Hideyuki Yoshioka^6,1, Youichi Shinozaki^1,2, Hiroyuki Kinouchi^6,1, Kenji F Tanaka⁷, Haruhiko Bito⁸, Makoto Tsuda^4,9, Schuichi Koizumi^1,2 (1. Yamanashi GLIA center, Interdisciplinary Graduate School of Medicine, University of Yamanashi, 2. Department of Neuropharmacology, Interdisciplinary Graduate School of Medicine, University of Yamanashi, 3. Department of Pediatrics, Interdisciplinary Graduate School of Medicine, University of Yamanashi, 4. Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, 5. Department of Neurophysiology, Hyogo College of Medicine, 6. Department of Neurosurgery, Interdisciplinary Graduate School of Medicine, University of Yamanashi, 7. Divison of Brain Sciences, Institute for Advanced Medical Research, Keio University School of Medicine, 8. Department of Neurochemistry, Graduate School of Medicine, The University of Tokyo, 9. Department of Life Innovation, Graduate School of Pharmaceutical Sciences, Kyushu University)

*Ryo Joel Nakatani¹, Erik De Schutter¹ (1. Okinawa Institute of Science and Technology)

*Deepak Chouhan¹, Akhilesh .¹, Vinod Tiwari¹ (1. Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (B.H.U.) Varanasi-221005 (U.P.) India )

*Fuminori Tsuruta¹, Sarasa Yano², Chihiro Maeda³, Natsu Asami³, Chihiro Hiraki³ (1. Inst of Life and Env Sci, Univ of Tsukuba, Tsukuba, Japan, 2. Grad Sch of Life and Env Sci, Univ of Tsukuba, Tsukuba, Japan, 3. Master's and Doctoral Program in Biology, Univ of Tsukuba, Tsukuba, Japan)